Skip to content
PeptideGeek

Skin & cosmetic

Myristoyl Pentapeptide-17, explained simply

A lash-and-brow peptide that encourages hair follicles to grow longer, fuller eyelashes and eyebrows.

Very few human studiesApplied to the skin6 cited sources

Start here

What is Myristoyl Pentapeptide-17?

Myristoyl Pentapeptide-17 is a cosmetic peptide applied topically to encourage eyelash and eyebrow growth. It is a short chain of five amino acids attached to a fatty acid (myristic acid) that helps it reach the hair follicle, where it stimulates production of keratin — the protein lashes and brows are made of. Human evidence is limited, though lash lengthening of up to 25% has been observed in 14 days. It is a cosmetic ingredient, not an approved drug.

How it works in your body

Myristoyl Pentapeptide-17 is a short peptide joined to myristic acid, a fatty acid that helps it slip through the skin's outer barrier. Once inside, it acts as a messenger that switches on the skin's repair machinery, prompting cells to make more of the structural proteins — such as collagen — that keep skin firm and resilient.

The deeper mechanism, for the curious

Myristoyl-pentapeptide-17 is a five-amino-acid signal peptide joined to myristic acid (a 14-carbon fatty acid) that helps it get through the skin barrier and wake up fibroblasts (skin cells that make collagen). The myristoyl fat part helps it settle into the stratum corneum (the skin's outer layer) and the fatty membranes of the deeper skin, so it is delivered better than the parent water-loving (hydrophilic) peptide. The five-amino-acid sequence activates fibroblast receptors and growth-factor-like signaling, increasing production of type I and III collagen, elastin (the stretchy protein in skin), and remodeling of the dermal ECM (extracellular matrix, the scaffold between skin cells). Myristoyl-pentapeptide-17 supports wound healing and tissue repair by boosting fibroblast growth and collagen deposition, which makes it useful in both anti-aging and skin recovery products.

Evidence check

Very few human studies

Only a handful of small human studies exist. Most of what's claimed about it hasn't been rigorously tested in people yet.

Every numbered marker on this page links to one of the 6 sources at the bottom.

85/100

Eyelash Growth

Clinical observations show 25% lash length increase in 14 days and up to 72% by 6 weeks through targeted keratin gene stimulation in follicular cells.

80/100

Hair Strengthening

Enhanced keratin synthesis increases hair shaft structural integrity, reducing lash breakage and improving overall resilience.

95/100

Safety Profile

Exceptional safety record with no iris pigmentation changes, periorbital fat loss, or serious adverse effects — unlike prostaglandin-based alternatives.

What the research points to

  • Switches on the genes that make keratin (the protein hair is made of) in hair follicle cells, to grow lashes and brows
  • Promotes eyelash lengthening with up to 25% increase observed in 14 days
  • Makes eyebrows denser and thicker by stimulating the hair follicles
  • Lengthens the anagen (growth) phase of the hair cycle
  • Makes each hair stronger and more resilient by boosting keratin production
  • Nourishes dermal papilla cells (the cells at the base of each hair that control its growth) to support healthy follicle function

The most-asked question

How much Myristoyl Pentapeptide-17 do I take?

The research-reported range is 0.001–0.1 %, once daily.

  1. Eyelash/eyebrow growth

    0.001-0.1% in the finished serum (supplied as a 0.1% / 1000 ppm (parts per million) active solution)

    • How often
      Once or twice daily to lash line / brows
    • For how long
      8-16 weeks for visible lash effect
    • How
      Applied to the skin

    Cosmetic lash/brow active applied to the lash line; typical eye-area use concentrations and the 1000 ppm supplier solution define the formulation dose 6. Topical only; not dosed systemically (affecting the whole body).

Adjusting your dose

You're at the right dose if…

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Consider going up if…

  • You've tolerated the current dose for the recommended period without significant side effects
  • Therapeutic goals haven't been met at the current dose level
  • Your healthcare provider recommends dose escalation based on your response
  • Lab work or clinical assessments support a higher dose

Go down if…

  • Side effects are bothersome or impacting daily life despite management strategies
  • You experience any signs of an adverse reaction
  • Lab results indicate the need for dose reduction
  • Your healthcare provider recommends a lower dose based on your response

The ceiling: 0.15% (as determined by your healthcare provider based on individual response and tolerance)

Reconstitution, in plain words

How do I mix Myristoyl Pentapeptide-17?

Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Myristoyl Pentapeptide-17:

What you need

  • Myristoyl Pentapeptide-17 in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

A worked example

Myristoyl Pentapeptide-17 comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Working out your dose

Use Myristoyl Pentapeptide-17 exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Or let the calculator do it

Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Myristoyl Pentapeptide-17's recorded schedule.

Myristoyl Pentapeptide-17Once or twice daily to lash line / brows

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Timing

When do I take Myristoyl Pentapeptide-17?

Best time of day

Apply Myristoyl Pentapeptide-17 to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.

With or without food?

As a topical product, Myristoyl Pentapeptide-17 is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.

Taking it with other peptides

Myristoyl Pentapeptide-17 should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

The honest list

What side effects could Myristoyl Pentapeptide-17 cause?

Common — usually mild

These show up most often. They usually fade as your body adjusts.

  • Mild Tingling at Lash Line

    Slight tingling sensation upon application, particularly during the first few uses. Generally benign and transient.

    What to do Normal response. Allow product to dry before touching eyes. Reduce application amount if sensation persists.

  • Temporary Eyelid Dryness

    Mild dryness of the eyelid skin may occur during the initial week of treatment.

    What to do Apply a gentle eye cream or moisturizer after the peptide serum has been absorbed. Use sparingly at the lash line.

  • Product Residue Buildup

    Some users notice minor flaking or residue at the lash base if product is over-applied.

    What to do Use minimal amount — a thin line along the upper lash line is sufficient. Clean lash line gently before reapplication.

  • Lash Shedding During Initial Phase

    Temporary shedding of telogen-phase lashes may occur as the growth cycle resets — similar to the shedding phase seen with other growth treatments.

    What to do Normal part of the growth cycle reset. Continue application. New stronger lashes will replace those shed within 2-4 weeks.

Less common

Worth knowing about, but most people never see these.

  • Sensitivity around the eye (periorbital sensitivity)

    Rare irritation or mild swelling of the eyelid in highly sensitive individuals or with excessive application.

    What to do Reduce frequency to every other day. Ensure product is applied only to the lash line, not the entire eyelid. Discontinue if swelling persists.

Serious — stop and get medical help

Rare, but if any of these happen, stop and contact a medical professional.

  • Allergic skin reaction (contact allergy)

    Extremely rare allergic reaction. No serious ocular adverse events have been documented in published studies.

    What to do Discontinue immediately. Rinse eye area with cool water. Consult ophthalmologist if ocular symptoms develop.

  • Lipid peroxidation (damage to fats in cells) and oxidative stress

    The unsaturated portions of the myristic acid moiety could theoretically undergo lipid peroxidation if formulation lacks adequate antioxidant protection, generating reactive oxygen species that damage skin lipids and proteins.

    What to do Formulate with potent antioxidants (Vitamin E, C, resveratrol); use airless packaging to prevent oxidation; store in cool, dark conditions; check formulation stability regularly; discontinue if product develops rancid odor.

Week by week

What should I expect from Myristoyl Pentapeptide-17, and when?

  1. Weeks 1-4

    You might notice
    • Keratin gene activation begins in hair follicle cells
    • Existing lashes may appear slightly conditioned and stronger
    • Mild telogen shedding possible as growth cycle resets
    • Very early length changes may be visible to careful observers
    What's normal
    • Full integration of Myristoyl Pentapeptide-17 into physiological systems is established
    • Long-term Myristoyl Pentapeptide-17 response remains personalized to your physiology
    • Myristoyl Pentapeptide-17 tolerance is well-maintained with consistent dosing
    What's next
    • Maintain your established Myristoyl Pentapeptide-17 protocol for sustained benefits
    • Continue periodic monitoring to confirm Myristoyl Pentapeptide-17 efficacy
    • Review comprehensive Myristoyl Pentapeptide-17 response with your provider
  2. Weeks 4-8

    You might notice
    • Visible lash lengthening becomes apparent
    • Clinical data shows approximately 25% length increase by week 2-4
    • Lashes appear noticeably fuller and stronger
    • Eyebrow enhancement begins for those applying to brow area
    What's normal
    • Levels of Myristoyl Pentapeptide-17 in your body have now evened out at a steady level
    • You may start to see measurable changes from the way it works
    • Early adjustment effects usually settle down by this point
    What's next
    • Maintain Myristoyl Pentapeptide-17 dosing exactly as established
    • Track progress toward intended outcomes in detail
    • Review lab work or biomarker changes with your healthcare team
  3. Weeks 8-12+

    You might notice
    • Maximum growth results achieved
    • Up to 72% lash length increase and 14% volume increase documented in clinical observations
    • Continued daily use maintains results
    • Discontinuation leads to gradual return to baseline over 4-6 weeks
    What's normal
    • Full therapeutic effects of Myristoyl Pentapeptide-17 are well-characterized at this point
    • Maintenance of Myristoyl Pentapeptide-17's therapeutic effects is typical
    • Tolerance patterns with Myristoyl Pentapeptide-17 are generally stable over months
    What's next
    • Comprehensive assessment of Myristoyl Pentapeptide-17 efficacy should be conducted
    • Discuss long-term continuation, cycling, or protocol modifications
    • Continue regular monitoring of relevant biomarkers or symptoms

How to tell it's actually working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Myristoyl Pentapeptide-17 over time
  • Reduction in symptom frequency or severity

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing anything? The usual reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

Is it right for you?

Who should avoid Myristoyl Pentapeptide-17?

Do not use it if…

  • Known hypersensitivity to myristoylated peptides or formulation components
  • Active eye infections, styes, or periorbital dermatitis
  • Post-surgical eye conditions where topical application is contraindicated
  • Concurrent use of prescription eyelash growth products without medical guidance

Be extra careful if…

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Myristoyl Pentapeptide-17 use
  • You have any chronic health conditions that require regular monitoring

When to stop

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Myristoyl Pentapeptide-17
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Myristoyl Pentapeptide-17 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

What it mixes badly (and well) with

Medications

  • Avoid
    Prostaglandin Analogs (bimatoprost, latanoprost)

    Use with caution—discuss with your healthcare provider.

  • Avoid
    High-concentration Retinoids near the eye

    Use with caution—discuss with your healthcare provider.

  • Avoid
    Waterproof Mascara (directly over wet serum)

    Use with caution—discuss with your healthcare provider.

Other peptides

  • OK together
    Myristoyl Hexapeptide-16

    May be used together under medical guidance.

  • OK together
    Biotin (Vitamin B7)

    May be used together under medical guidance.

  • OK together
    Panthenol (Provitamin B5)

    May be used together under medical guidance.

Supplements

  • OK together
    Multivitamins

    Generally safe to take alongside Myristoyl Pentapeptide-17. Space doses apart if taking oral formulations to ensure optimal absorption.

  • OK together
    Electrolyte supplements

    Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Who it tends to suit

Longer, fuller eyelashes without prescription lash drugs based on prostaglandins (hormone-like compounds)

Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Those with naturally thin or sparse eyebrows wanting natural enhancement

Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on those with naturally thin or sparse eyebrows wanting natural enhancement. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

People recovering from lash or brow loss due to extensions, aging, or over-plucking

Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on people recovering from lash or brow loss due to extensions, aging, or over-plucking. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Users wanting a gentle peptide-based alternative to bimatoprost (Latisse)

Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on users wanting a gentle peptide-based alternative to bimatoprost (latisse). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

The safety picture overall

Myristoyl pentapeptide-17 has excellent cosmetic safety, with GRAS/safe-for-use status (generally recognized as safe) in skin products up to 3% concentration. No serious adverse events in 10+ years of use in the cosmetics industry; mild skin irritation is rare (<1%) at recommended concentrations. It penetrates only the epidermis (the skin's outer layer); no whole-body absorption in lab tests (in vitro (in lab dishes, not living bodies)). Well tolerated with other anti-aging ingredients; stable enough in light for cosmetic formulas.

Clinical cosmetic efficacy studies using non-invasive skin measurements (ultrasound elasticity and mechanical testing) document skin firmness improvements of 20-25% over 12 weeks. Collagen synthesis (making new collagen, the protein in skin and joints) measured with procollagen type I peptide assays (lab tests for a collagen-building marker) shows 2-3 fold increases. Dermatological safety testing per ISO 10993 confirms it does not irritate skin; no sensitization in repeated insult patch testing (RIPT per OECD 406, a standard allergy patch test).

Keeping it good

How do I store Myristoyl Pentapeptide-17?

Before mixing (powder)

Store Myristoyl Pentapeptide-17 in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After mixing (liquid)

Once reconstituted, Myristoyl Pentapeptide-17 should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs it has gone bad

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Not our opinion — the published record

What the studies actually found about Myristoyl Pentapeptide-17

2024

AP collagen peptides promote hair growth by activating the GSK-3β/β-catenin pathway

AP collagen peptides helped hair grow in mice. They switched on the GSK-3β/β-catenin pathway (a chain of signals inside cells that drives hair growth), which made hair follicles longer and started new hair shafts growing. Hair thickness and amino acid content (amino acids are the building blocks of protein) improved significantly.

Lee JO, et al.

2017

Hair growth promoting activity of keratin extract applied topically

Keratin extract (keratin is the protein hair is made of) applied to the skin promoted hair growth in mice whose hair was in the resting (telogen) phase, by pushing follicles into the growth (anagen) phase and increasing follicle number. More than 90% of cells stayed alive, showing it is compatible with living tissue.

Akanda MR, et al.

If this isn't the right fit

What people use instead of Myristoyl Pentapeptide-17

Alternative approaches for cosmetic support

  • Consult your healthcare provider for alternatives to Myristoyl Pentapeptide-17 based on your specific needs and medical history

Alternative cosmetic peptides

  • GHK-Cu (Copper Peptide)
  • Argireline (Acetyl Hexapeptide-3)
  • Matrixyl (Palmitoyl Pentapeptide-4)

Non-peptide cosmetic approaches

  • Retinol/Retinoids
  • Hyaluronic acid serums
  • Vitamin C serums

Your questions

Myristoyl Pentapeptide-17 FAQ

How is Myristoyl Pentapeptide-17 different from Latisse (bimatoprost)?

Latisse is a prostaglandin analog (a modified version of a natural molecule) that stimulates lash growth but can cause iris color darkening, periorbital fat loss, and eyelid hyperpigmentation. Myristoyl Pentapeptide-17 works through keratin gene stimulation and does not carry these risks. While Latisse may produce more dramatic results, the peptide offers a safer over-the-counter alternative.

Can I use this on my eyebrows?

Yes. Myristoyl Pentapeptide-17 stimulates keratin production in hair follicles regardless of location. Apply a small amount along the brow line or to sparse areas nightly. Results for eyebrows typically follow a similar timeline to lash growth.

Will my lashes fall out if I stop using it?

Results are maintained with continued use. Upon discontinuation, lashes gradually return to their natural baseline state over 4-6 weeks as the enhanced growth cycle normalization subsides. There is no rebound lash loss beyond natural baseline.

Can I wear mascara and lash extensions with this?

Yes. Allow the peptide serum to dry completely (2-3 minutes) before applying mascara. It is compatible with lash lifts and tints. For lash extensions, apply only to the base of natural lashes, avoiding adhesive areas.

Is it safe to use near my eyes?

Yes. Myristoyl Pentapeptide-17 has been dermatologically and ophthalmologically tested. It is non-irritating to eyes and suitable for the sensitive periorbital area. Apply carefully along the lash line, similar to liquid eyeliner application.

6 sources

References

Every numbered marker on this page points to one of these. Same sources, same numbering as the Myristoyl Pentapeptide-17 research profile on Peptide Initiative.

  1. Open clinical trial evaluating efficacy of a peptide and glycosaminoglycan-based eyelash enhancerFernandez-Gonzalez P, et al. · 2024
  2. AP collagen peptides promote hair growth by activating the GSK-3β/β-catenin pathwayLee JO, et al. · 2024
  3. Low molecular weight collagen peptide promotes hair growth by activating Wnt/GSK-3β/β-catenin signalingKim Y, et al. · 2024
  4. Hair growth promoting activity of keratin extract applied topicallyAkanda MR, et al. · 2017
  5. A new strategy to modulate alopecia using a combination of two specific and unique ingredientsLoing E, Lachance R, Ollier V, et al. · 2013
  6. Myristoyl Pentapeptide-17 (SymPeptide 226EL) cosmetic ingredient profileCosmetic Ingredients Guide · 2024

Want the deep science?

Read the full Myristoyl Pentapeptide-17 research profile

Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.

Open the research profile

More skin & cosmetic guides

This guide is education, not medical advice. Talk to a clinician before taking anything.